Global Acute Myeloid Leukemia Treatment Market Growth 2018-2023
Published On: October 2018
 
Report ID:351829
 
 
Pages: 134




Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.

Over the next five years, LPI(LP Information) projects that Acute Myeloid Leukemia Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Acute Myeloid Leukemia Treatment market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Acute Myeloid Leukemia Treatment market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

DC regimen

AVD Regimen

VCD regimen

Segmentation by application:

Hospital

Clinic

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Ambit Biosciences Corporation

Celgene Corporation

Cephalon

Clavis Pharma

Eisai

Genzyme Corporation

Sunesis Pharmaceuticals

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Acute Myeloid Leukemia Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Acute Myeloid Leukemia Treatment market by identifying its various subsegments.

Focuses on the key global Acute Myeloid Leukemia Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Acute Myeloid Leukemia Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Acute Myeloid Leukemia Treatment submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Acute Myeloid Leukemia Treatment Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Acute Myeloid Leukemia Treatment Consumption 2013-2023

2.1.2 Acute Myeloid Leukemia Treatment Consumption CAGR by Region

2.2 Acute Myeloid Leukemia Treatment Segment by Type

2.2.1 DC regimen

2.2.2 AVD Regimen

2.2.3 VCD regimen

2.3 Acute Myeloid Leukemia Treatment Consumption by Type

2.3.1 Global Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)

2.3.2 Global Acute Myeloid Leukemia Treatment Revenue and Market Share by Type (2013-2018)

2.3.3 Global Acute Myeloid Leukemia Treatment Sale Price by Type (2013-2018)

2.4 Acute Myeloid Leukemia Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Acute Myeloid Leukemia Treatment Consumption by Application

2.5.1 Global Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)

2.5.2 Global Acute Myeloid Leukemia Treatment Value and Market Share by Application (2013-2018)

2.5.3 Global Acute Myeloid Leukemia Treatment Sale Price by Application (2013-2018)

3 Global Acute Myeloid Leukemia Treatment by Players

3.1 Global Acute Myeloid Leukemia Treatment Sales Market Share by Players

3.1.1 Global Acute Myeloid Leukemia Treatment Sales by Players (2016-2018)

3.1.2 Global Acute Myeloid Leukemia Treatment Sales Market Share by Players (2016-2018)

3.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players

3.2.1 Global Acute Myeloid Leukemia Treatment Revenue by Players (2016-2018)

3.2.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players (2016-2018)

3.3 Global Acute Myeloid Leukemia Treatment Sale Price by Players

3.4 Global Acute Myeloid Leukemia Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Acute Myeloid Leukemia Treatment Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Acute Myeloid Leukemia Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Acute Myeloid Leukemia Treatment by Regions

4.1 Acute Myeloid Leukemia Treatment by Regions

4.1.1 Global Acute Myeloid Leukemia Treatment Consumption by Regions

4.1.2 Global Acute Myeloid Leukemia Treatment Value by Regions

4.2 Americas Acute Myeloid Leukemia Treatment Consumption Growth

4.3 APAC Acute Myeloid Leukemia Treatment Consumption Growth

4.4 Europe Acute Myeloid Leukemia Treatment Consumption Growth

4.5 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Growth

5 Americas

5.1 Americas Acute Myeloid Leukemia Treatment Consumption by Countries

5.1.1 Americas Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)

5.1.2 Americas Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)

5.2 Americas Acute Myeloid Leukemia Treatment Consumption by Type

5.3 Americas Acute Myeloid Leukemia Treatment Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Acute Myeloid Leukemia Treatment Consumption by Countries

6.1.1 APAC Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)

6.1.2 APAC Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)

6.2 APAC Acute Myeloid Leukemia Treatment Consumption by Type

6.3 APAC Acute Myeloid Leukemia Treatment Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Acute Myeloid Leukemia Treatment by Countries

7.1.1 Europe Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)

7.1.2 Europe Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)

7.2 Europe Acute Myeloid Leukemia Treatment Consumption by Type

7.3 Europe Acute Myeloid Leukemia Treatment Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Acute Myeloid Leukemia Treatment by Countries

8.1.1 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)

8.2 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Type

8.3 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Acute Myeloid Leukemia Treatment Distributors

10.3 Acute Myeloid Leukemia Treatment Customer

11 Global Acute Myeloid Leukemia Treatment Market Forecast

11.1 Global Acute Myeloid Leukemia Treatment Consumption Forecast (2018-2023)

11.2 Global Acute Myeloid Leukemia Treatment Forecast by Regions

11.2.1 Global Acute Myeloid Leukemia Treatment Forecast by Regions (2018-2023)

11.2.2 Global Acute Myeloid Leukemia Treatment Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Acute Myeloid Leukemia Treatment Forecast by Type

11.8 Global Acute Myeloid Leukemia Treatment Forecast by Application

12 Key Players Analysis

12.1 Ambit Biosciences Corporation

12.1.1 Company Details

12.1.2 Acute Myeloid Leukemia Treatment Product Offered

12.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 Ambit Biosciences Corporation News

12.2 Celgene Corporation

12.2.1 Company Details

12.2.2 Acute Myeloid Leukemia Treatment Product Offered

12.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Celgene Corporation News

12.3 Cephalon

12.3.1 Company Details

12.3.2 Acute Myeloid Leukemia Treatment Product Offered

12.3.3 Cephalon Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 Cephalon News

12.4 Clavis Pharma

12.4.1 Company Details

12.4.2 Acute Myeloid Leukemia Treatment Product Offered

12.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Clavis Pharma News

12.5 Eisai

12.5.1 Company Details

12.5.2 Acute Myeloid Leukemia Treatment Product Offered

12.5.3 Eisai Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 Eisai News

12.6 Genzyme Corporation

12.6.1 Company Details

12.6.2 Acute Myeloid Leukemia Treatment Product Offered

12.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 Genzyme Corporation News

12.7 Sunesis Pharmaceuticals

12.7.1 Company Details

12.7.2 Acute Myeloid Leukemia Treatment Product Offered

12.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 Sunesis Pharmaceuticals News

...

13 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.